Inflammation is correlated with severity and outcome of cerebral venous thrombosis
- PMID: 30477534
- PMCID: PMC6260678
- DOI: 10.1186/s12974-018-1369-0
Inflammation is correlated with severity and outcome of cerebral venous thrombosis
Abstract
Background: Few studies have suggested a relationship between inflammation and cerebral venous thrombosis (CVT). This retrospective study aimed to explore the changes in inflammation in different CVT stages and the correlation between inflammation and severity and outcome of CVT.
Methods: In total, 95 suitable patients with CVT and 41 controls were compared. Patients with CVT were divided into three groups. The inflammatory factors studied included hypersensitive C-reactive protein (Hs-CRP), interleukin-6 (IL-6), and neutrophil-to-lymphocyte ratio (NLR) in the peripheral blood and immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin G (IgG) in the cerebrospinal fluid (CSF). The severity of CVT was evaluated with the modified Rankin Scale (mRS), the National Institutes of Health Stroke Scale (NIHSS), fundus condition, intracranial pressure (ICP), and complications on admission. The short-term outcome was evaluated with the mRS at discharge.
Results: The following results were obtained: (1) Inflammatory factor levels in patients with CVT were higher than those in the controls. (2) Inflammatory factor levels in the acute and subacute stages were significantly higher than those in the chronic stage (all P < 0.05). (3) Serum NLR and CSF IgM levels were positively related to baseline degree of disability (odds ratio [OR], 1.279, 95% confidence interval [CI] 1.009-1.621, P = 0.042; OR 1.402, 95% CI 1.036-1.896, P = 0.028). The Hs-CRP level was positively correlated with the baseline occurrence of seizure (OR 1.040, 95% CI 1.001-1.080, P = 0.043). The baseline serum NLR (r = 0.244, P = 0.017), CSF IgA (r = 0.615, P < 0.001), CSF IgM (r = 0.752, P < 0.001), and CSF IgG (r = 0.248, P = 0.015) levels were positively associated with NIHSS. (4) The baseline NLR was significantly associated with high risk of poor outcome at discharge (OR 1.339, 95% CI 1.097-1.784, P = 0.007). Moreover, the ROC showed that NLR ≥ 4.205 could better predict the poor outcome at discharge. The data were analyzed using SPSS.
Conclusions: Inflammation may develop after CVT and gradually decrease during the course. Inflammation was significantly correlated with severity on admission and short-term poor outcome at discharge in CVT.
Keywords: Cerebral venous thrombosis; Inflammation; Outcome; Severity; Stage.
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the Institutional Review Board of Xuanwu Hospital.
Consent for publication
The authors agree to publish.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



Similar articles
-
Serum neuron specific enolase may be a marker to predict the severity and outcome of cerebral venous thrombosis.J Neurol. 2018 Jan;265(1):46-51. doi: 10.1007/s00415-017-8659-9. Epub 2017 Nov 11. J Neurol. 2018. PMID: 29128928
-
Elevated fasting blood glucose is predictive of the severity and poor outcome in nondiabetic patients with cerebral venous thrombosis.J Neurol Sci. 2020 Oct 15;417:117017. doi: 10.1016/j.jns.2020.117017. Epub 2020 Jul 17. J Neurol Sci. 2020. PMID: 32771710
-
Inflammatory Biomarkers Correlate with Time Evolution in Cerebral Venous Thrombosis.J Stroke Cerebrovasc Dis. 2021 Jul;30(7):105844. doi: 10.1016/j.jstrokecerebrovasdis.2021.105844. Epub 2021 May 11. J Stroke Cerebrovasc Dis. 2021. PMID: 33984744
-
Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and literature review.J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105145. doi: 10.1016/j.jstrokecerebrovasdis.2020.105145. Epub 2020 Jul 28. J Stroke Cerebrovasc Dis. 2020. PMID: 32912503 Review.
-
Shunting in acute cerebral venous thrombosis: a systematic review.Cerebrovasc Dis. 2014;37(1):38-42. doi: 10.1159/000356524. Epub 2013 Dec 18. Cerebrovasc Dis. 2014. PMID: 24356100 Review.
Cited by
-
Inflammation and Severe Cerebral Venous Thrombosis.Front Neurol. 2022 Jul 22;13:873802. doi: 10.3389/fneur.2022.873802. eCollection 2022. Front Neurol. 2022. PMID: 35937062 Free PMC article. Review.
-
Prognostic nutritional index predicts clinical outcomes in patients with cerebral venous sinus thrombosis.BMC Neurol. 2021 Oct 21;21(1):404. doi: 10.1186/s12883-021-02436-w. BMC Neurol. 2021. PMID: 34674659 Free PMC article.
-
Anti-inflammatory Effect of Batroxobin Combined With Anticoagulation in Patients With Cerebral Venous Thrombosis.Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241264516. doi: 10.1177/10760296241264516. Epub 2024 Jul 21. Clin Appl Thromb Hemost. 2024. PMID: 39033421 Free PMC article.
-
Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients With Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis.Front Neurol. 2019 Oct 4;10:1032. doi: 10.3389/fneur.2019.01032. eCollection 2019. Front Neurol. 2019. PMID: 31636598 Free PMC article.
-
Inflammation in Cerebral Venous Thrombosis.Front Immunol. 2022 Apr 4;13:833490. doi: 10.3389/fimmu.2022.833490. eCollection 2022. Front Immunol. 2022. PMID: 35444662 Free PMC article. Review.
References
-
- Suzanne MS, de Sousa DA, José MF, et al. Cerebral venous thrombosis. Neurology. 2017;13:555–565. - PubMed
-
- Chinese society of neurology The guidance of diagnosis and treatment for cerebral venous thrombosis in China 2015. Chin J Neurol. 2015;48:819–829.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous